Efficacy and safety of once‐weekly insulin icodec versus once‐daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the <scp>ONWARDS</scp> 1, 2 and 4 trials
Icodec improved glycaemic control to a similar degree as once-daily basal insulin comparators while maintaining low levels of clinically significant or severe hypoglycaemia. The findings support icodec use in Japanese individuals with different levels of type 2 diabetes progression.
Authors
- Yuiko Yamamoto
- Toshimasa Yamauchi (ORCID: https://orcid.org/0000-0003-4827-6404)
- Hirotaka Watada (ORCID: https://orcid.org/0000-0001-5961-1816)
- Tomoyuki Nishida (ORCID: https://orcid.org/0009-0004-5812-7167)
- Björg Ásbjörnsdóttir
- Rimei Nishimura (ORCID: https://orcid.org/0000-0003-3335-7471)
- Takashi Kadowaki
Institutions
- Jikei University School of Medicine (JP)
- Novo Nordisk (Denmark) (DK)
- Juntendo University (JP)
- Toranomon Hospital (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1111/dom.15960
- Citations
- 3
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- Novo Nordisk